Now showing items 1-10 of 390
Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort.
(Wiley Publishing Asia Pty Ltd., 2015)
AIM: To determine the association between duration of untreated psychosis (DUP) and symptoms remission in a hospitalized first-episode psychosis cohort. METHODS: Inpatients with a first-episode non-affective psychosis ...
Family context and duration of untreated psychosis (DUP): Results from the Sao Paulo Study
(ELSEVIER SCIENCE BV, 2010)
Background: Duration of untreated psychosis (DUP) depends on several factors, including socio-demographic, socioeconomic, clinical and contextual circumstances, such as availability of mental health services. Living ...
BDNF as a biomarker of cognition in schizophrenia/psychosis: An updated review
(Frontiers Media, 2021)
Brain Derived Neurotrophic Factor (BDNF) has been linked to cognitive symptoms of schizophrenia, which has been documented in previous reviews by several authors. However, a trend has recently emerged in this field moving ...
Acute psychosis in systemic lupus erythematosus
(SpringerNew YorkEUA, 2008)
Antinuclear antibodies testing as a routine screening for systemic lupus erythematosus in patients presenting first-episode psychosis
Aims: This report discusses the use of antinuclear antibody (ANA) detection as a screening test for neuropsychiatry systemic lupus erythematosus (NPSLE) in patients presenting a first-episode psychosis. Methods: We reviewed ...
Psychiatric outcome of epilepsy surgery in patients with psychosis and temporal lobe drug-resistant epilepsy: a prospective case series
OBJECTIVES: Temporal lobe resistant epilepsy has been associated with a high incidence of psychotic disorders; however, there are many controversies; while some patients get better after surgery from their psychiatric ...